Projects per year
Abstract
Human cytomegalovirus (HCMV) is a ubiquitous human pathogen that can cause severe disease in immunocompromised individuals, transplant recipients, and to the developing foetus during pregnancy. There is no protective vaccine currently available, and with only a limited number of antiviral drug options, resistant strains are constantly emerging. Successful completion of HCMV replication is an elegant feat from a molecular perspective, with both host and viral processes required at various stages. Remarkably, HCMV and other herpesviruses have protracted replication cycles, large genomes, complex virion structure and complicated nuclear and cytoplasmic replication events. In this review, we outline the 10 essential stages the virus must navigate to successfully complete replication. As each individual event along the replication continuum poses as a potential barrier for restriction, these essential checkpoints represent potential targets for antiviral development.
Original language | English |
---|---|
Article number | 1053139 |
Number of pages | 34 |
Journal | Frontiers in Cell and Developmental Biology |
Volume | 10 |
DOIs | |
Publication status | Published - 25 Nov 2022 |
Keywords
- antiviral therapeutic
- HCMV (human cytomegalovirus)
- herpes viral infection
- viral replication
- virion assembly
Projects
- 1 Finished
-
Blocking Human Cytomegalovirus: Targeting Host Organelle Remodelling and the Viral AssemblyComplex
Mathias, R. (Primary Chief Investigator (PCI))
National Health and Medical Research Council (NHMRC) (Australia)
1/01/16 → 31/12/18
Project: Research